Showing results (1481-1490 of 1,667) with videos related to
Sort By:
Pageof 167
European Journal of Cancer (Oxford, England : 1990)|January 19, 2024
Efficacy of immune checkpoint inhibitors for metastatic colorectal cancer with microsatellite instability in second or latter line using synthetic control arms: A non-randomised evaluationRomain Cohen, Morteza Raeisi, Benoist Chibaudel, et al.Cancer Medicine|July 18, 2019
Impact on health-related quality of life deterioration-free survival of a first-line therapy combining nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trialEmilie Charton, Jean-Baptiste Bachet, Pascal Hammel, et al.The Journal of Experimental Medicine|March 28, 2023
The interweaved signatures of common-gamma-chain cytokines across immunologic lineagesAlev Baysoy, Kumba Seddu, Tamara Salloum, et al.Arthritis and Rheumatism|April 11, 2003
Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disordersIsao Matsumoto, David M Lee, Raphaela Goldbach-Mansky, et al.Journal of Inherited Metabolic Disease|June 26, 2015
Mitochondrial trifunctional protein deficiency in human cultured fibroblasts: effects of bezafibrateFatima Djouadi, Florence Habarou, Carole Le Bachelier, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 18, 2024
E-Cadherin Mutational Landscape and Outcomes in Breast Invasive Lobular CarcinomaLounes Djerroudi, Amel Bendali, Laetitia Fuhrmann, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2011
EGFR- and VEGF(R)-targeted small molecules show synergistic activity in colorectal cancer models refractory to combinations of monoclonal antibodiesVirginie Poindessous, Djamila Ouaret, Karima El Ouadrani, et al.Cancers|September 23, 2022
Targeting the Tumor Microenvironment through mTOR Inhibition and Chemotherapy as Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: The CAPRA StudyDiane Evrard, Clément Dumont, Michel Gatineau, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 13, 2022
Breast carcinomas with osteoclast-like giant cells: a comprehensive clinico-pathological and molecular portrait and evidence of RANK-L expressionJoanna Cyrta, Camille Benoist, Julien Masliah-Planchon, et al.Frontiers in Oncology|September 19, 2022
Phase II INTERACT-ION study: ezabenlimab (BI 754091) and mDCF (docetaxel, cisplatin, and 5-fluorouracil) followed by chemoradiotherapy in patients with Stage III squamous cell anal carcinomaStefano Kim, Jihane Boustani, Dewi Vernerey, et al.Pageof 167